Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Shanghai Healthcare Capital (SHC) is a private equity firm based in Shanghai, China, established with the approval of the Shanghai municipal government. It is managed by SIIC Capital, with Shanghai Pharma as one of its founding and strategic Limited Partners. SHC focuses on biotech and healthcare investments globally, with a goal to invest in early-stage and best-in-class innovators with a pipeline of therapies for improving the lives and long-term outcomes of patients. The fund's total scale is around $7 billion USD, and it plays a key role in China's industrial policy to upgrade its domestic medical manufacturing capabilities.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Shanghai Healthcare Capital's primary investment focus?
- Shanghai Healthcare Capital primarily invests in biotechnology and healthcare companies.
- Which sectors has Shanghai Healthcare Capital invested in?
- Shanghai Healthcare Capital has invested in the Health Tech & Life Sciences sector.
- Can you name a notable portfolio company of Shanghai Healthcare Capital?
- A notable portfolio company of Shanghai Healthcare Capital is Biomica, which focuses on microbiome-based therapeutics.
- What was Shanghai Healthcare Capital's most recent investment activity?
- Shanghai Healthcare Capital participated in an A Round for Biomica in December 2022, which raised $37M.
- What stage of funding does Shanghai Healthcare Capital typically participate in?
- Shanghai Healthcare Capital has participated in A Round funding stages.
- When was Shanghai Healthcare Capital founded?
- Shanghai Healthcare Capital's founding date is not available in the provided data.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2020 |
|---|